Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Phenotype C0032226|pleural disease
Sentences 3
PubMedID- 21552017 Aim: the aim of this study was to assess the utility of dual-time-point f-18 fluorodeoxyglucose positron emission tomography (f-18 fdg pet) in differentiating benign from malignant pleural disease, in patients with non-small-cell lung cancer.
PubMedID- 21616674 Objectives: the prognosis of non-small-cell lung cancer (nsclc) patients with malignant pleural disease (mpd), characterized by malignant pleural effusion and/or malignant pleural nodules, is reported to be poor, and patients with mpd are generally not subjected to surgery.
PubMedID- 21697244 pleural disease in lung cancer can be benign or malignant with the latter carrying a grave prognosis.

Page: 1